IP Library Granted Patent US 7,820,387
Granted Patent B2
US 7,820,387 · App. 11/926,120 · Granted Oct 26, 2010

Reactions on a solid surface

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,820,387
App. No.
11/926,120
Granted
Oct 26, 2010
Kind
B2
Abstract

The present invention relates to compositions and methods for the detection and characterization of nucleic acid sequences and variations in nucleic acid sequences. The present invention relates to methods for forming a nucleic acid cleavage structure on a solid support and cleaving the nucleic acid cleavage structure in a site-specific manner. For example, in some embodiments, a 5′ nuclease activity from any of a variety of enzymes is used to cleave the target-dependent cleavage structure, thereby indicating the presence of specific nucleic acid sequences or specific variations thereof.

Claims (35)

1. A method for characterizing a nucleic acid comprising:

a) providing:

i. a sample suspected of containing a target nucleic acid;

ii. oligonucleotides capable of hybridizing to said target nucleic acid to form an invasive cleavage structure, wherein said oligonucleotides comprise first and second oligonucleotides, said first oligonucleotide comprising a portion complementary to a first region of said target nucleic acid and said second oligonucleotide comprising a 3′ portion and a 5′ portion, said 5′ portion complementary to a second region of said target nucleic acid downstream of and contiguous to said first portion of said target nucleic acid;

iii. a solid support, wherein one or more of said oligonucleotides is attached to said solid support; and

iv. an archaeal FEN-1 endonuclease active at 55° C. and above for detecting the presence of an invasive cleavage structure;

b) exposing said sample to said oligonucleotides and said FEN-1 endonuclease, wherein said exposing said sample to said oligonucleotides and said FEN-1 endonuclease comprises exposing said sample to said oligonucleotides and said FEN-1 endonuclease under conditions wherein an invasive cleavage structure is formed between a target nucleic acid and said oligonucleotides if said target nucleic acid is present in said sample; and

c) detecting said invasive cleavage structure.

2. The method of claim 1 , wherein one or more of said first oligonucleotides and/or one or more of said second oligonucleotides is attached to said solid support.

3. The method of claim 1 , wherein said first oligonucleotides comprise a fluorescent dye.

4. The method of claim 3 , wherein said first oligonucleotides further comprise a quencher molecule.

5. The method of claim 1 , further providing a spacer molecule, wherein said one or more oligonucleotides is attached to said solid support through said spacer molecule.

6. The method of claim 5 , wherein said spacer molecule is selected from the group consisting of a carbon chain, a polynucleotide, biotin, and a polyglycol.

7. The method of claim 1 , wherein said solid support comprises a support selected from the group consisting of a glass solid support, a plastic solid support, a silicon solid support, a latex solid support and a hydrogel solid support.

8. The method of claim 1 , wherein said solid support comprises a solid support selected from the group consisting of a bead, a multi-well plate, a column, and a microarray.

9. The method of claim 1 , wherein said solid support is coated with a material selected from the group consisting of gold and streptavidin.

10. A method for cleaving multiple oligonucleotides comprising:

a) providing:

i. a plurality of first oligonucleotides attached to a solid support;

ii. a second oligonucleotide attached to said solid support; and

iii. a cleavage agent comprising an archaeal FEN-1 endonuclease active at 55° C. and above;

wherein said first oligonucleotides comprise a portion complementary to a first region of a target nucleic acid; and wherein said second oligonucleotide comprises a 3′ portion and a 5′ portion, said 5′ portion complementary to a second region of said target nucleic acid downstream of and contiguous to said first portion of said target nucleic acid;

b) exposing said solid support to said cleavage agent under conditions such that:

i. a first cleavage structure is formed, said first cleavage structure comprising one of said first oligonucleotides and said second oligonucleotide;

ii. said cleavage agent cleaves said first oligonucleotide in said first cleavage structure to produce a first cleavage fragment;

iii. after cleavage of said first oligonucleotide, a second cleavage structure is formed, said second cleavage structure comprising a second of said first oligonucleotides and said second oligonucleotide;

iv. said cleavage agent cleaves said first oligonucleotide in said second cleavage structure to produce a second cleavage fragment; wherein said conditions comprise exposing a target nucleic acid to said solid support; and

c) detecting the presence of said first or said second cleavage fragments.

11. The method of claim 10 , wherein said second oligonucleotide is attached to said solid support through a spacer molecule.

12. The method of claim 11 , wherein said spacer molecule is selected to allow said second oligonucleotide to form a cleavage structure with three or more of said first oligonucleotides.

13. The method of claim 12 , wherein said spacer molecule is selected to allow said second oligonucleotide to form a cleavage structure with ten or more of said first oligonucleotides.

14. The method of claim 11 , wherein said spacer molecule is selected from the group consisting of a carbon chain, a polynucleotide, biotin, and a polyglycol.

15. The method of claim 10 , wherein said solid support comprises a support selected from the group consisting of a glass solid support, a plastic solid support, a silicon solid support, a latex solid support and a hydrogel solid support.

16. The method of claim 10 , wherein said solid support comprises a solid support selected from the group consisting of a bead, a multi-well plate, a column, and a microarray.

17. The method of claim 10 , wherein said solid support is coated with a material selected from the group consisting of gold and streptavidin.

Assignments (10)
RELEASE OF SECURITY INTEREST Recorded Apr 28, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: HOLOGIC, INC., ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO DIRECT RADIOGRAPHY CORP.; CYTYC CORPORATION, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO BIOLUCENT, LLC; CYTYC SURGICAL PRODUCTS, LLC, AS SUCCESSOR-BY-CONVERSION TO CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; GEN-PROBE INCORPORATED, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.
Reel/Frame 075566/0039 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 035820 FRAME: 0239. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST RELEASE. Recorded Nov 9, 2017
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 044727/0529 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 028810 FRAME: 0745. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT. Recorded Nov 9, 2017
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 044432/0565 →
MERGER Recorded Oct 23, 2015
From: THIRD WAVE AGBIO, INC.; THIRD WAVE TECHNOLOGIES, INC.
To: GEN-PROBE INCORPORATED
Reel/Frame 036934/0796 →
SECURITY AGREEMENT Recorded Aug 7, 2015
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; DIRECT RADIOGRAPHY CORP.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 036307/0199 →
SECURITY INTEREST RELEASE REEL/FRAME 028810/0745 Recorded Jun 4, 2015
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 035820/0239 →
SECURITY AGREEMENT Recorded Aug 1, 2012
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 028810/0745 →
TERMINATION OF PATENT SECURITY AGREEMENTS AND RELEASE OF SECURITY INTERESTS Recorded Aug 26, 2010
From: GOLDMAN SACHS CREDIT PARTNERS, L.P., AS COLLATERAL AGENT
To: HOLOGIC, INC.; R2 TECHNOLOGY, INC.; SUROS SURGICAL SYSTEMS, INC.; BIOLUCENT, LLC; DIRECT RADIOGRAPHY CORP.; CYTYC SURGICAL PRODUCTS II LIMITED PARTNERSHIP; CYTYC SURGICAL PRODUCTS LIMITED PARTNERSHIP; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS III, INC.; CYTYC PRENATAL PRODUCTS CORP.; THIRD WAVE TECHNOLOGIES, INC.
Reel/Frame 024892/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 1, 2008
From: NERI, BRUCE P.; HALL, JEFF G.; LYAMICHEV, VICTOR I.; SMITH, LLOYD M.
To: THIRD WAVE TECHNOLOGIES, INC.
Reel/Frame 021331/0075 →
SECURITY AGREEMENT Recorded Jul 29, 2008
From: THIRD WAVE TECHNOLOGIES, INC.
To: GOLDMAN SACHS CREDIT PARTNERS L.P., AS COLLATERAL AGENT
Reel/Frame 021301/0780 →